Engineering Precision: Advancing CAR-T Research Beyond the Oncology Paradigm
The success of Chimeric Antigen Receptor (CAR) T-cell technology in targeting hematologic malignancies has established a robust blueprint for synthetic immunology. However, for researchers in...